Novo Nordisk Pharmatech lands record profits in 2020
Novo Nordisk-owned company Novo Nordisk Pharmatech landed record profits in 2020. The firm's soon-to-be-former managing director reasons that this owes to solid advances in two product groups in particular.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN
Novo Nordisk' supply-focused subsidiary Novo Nordisk Pharmatech came out of 2020 with a record profit, according to the 2020 annual financial report for the latter.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk Pharmatech to open new sales office in US
For subscribers
.jpg&w=384&q=75)
